美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Bicara Therapeutics

15.51

+1.6912.23%

盤後：15.510.00000.00%17:52 EDT

成交量：117.58萬

成交額：1,807.42萬

市值：8.46億

市盈率：-3.83

高：16.22

開：14.10

低：13.66

收：13.82

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Bicara Therapeutics

交易所：

NASDAQ

成立時間：

2018

員工人數：

55

公司地址：

116 Huntington Avenue,Suite 703,Boston,Massachusetts,United States

官網：

http://www.bicara.com

郵編：

02116

電話：

傳真：

- -

簡介：

Bicara Therapeutics Inc.於2018年12月12日在特拉華州註冊成立。他們是一家臨床階段的生物製藥公司，致力於為實體瘤患者帶來變革性的雙功能療法。他們的主要項目阿法是一種雙功能抗體，它結合了兩個臨床驗證的靶點，即表皮生長因子受體（EGFR）導向的單克隆抗體和結合人類轉化生長因子β（TGF-b）的結構域。通過這種雙靶向機制，阿法有可能通過同時阻斷癌症細胞固有的EGFR存活和增殖，以及腫瘤微環境（TME）中的免疫抑制性TGF-b信號傳導，發揮強大的抗腫瘤活性。Ficerafusp alfa通過與腫瘤細胞上的EGFR結合，將TGF-b抑製劑直接引入TME，他們認為這將導致持久的反應和總生存率或OS的增加，同時減少通常與全身TGF-b抑制相關的不良反應。

董事

名稱

職位

Claire Mazumdar

Chief Executive Officer and Director

Michael Powell

Chairperson of the Board

Ryan Cohlhepp, Pharm.D

President, Chief Operating Officer and Director

Carolyn Ng

Director

Christopher Bowden

Director

Heath Lukatch

Director

Jake Simson

Director

Kate Haviland

Director

Kiran Mazumdar Shaw

Director

Nils Lonberg

Director

Scott Robertson

Director

Vijay Kuchroo, D.V.M

Director

股東

名稱

職位

Claire Mazumdar

Chief Executive Officer and Director

Ryan Cohlhepp, Pharm.D

President, Chief Operating Officer and Director

Ivan Hyep

Chief Financial Officer

David Raben

Chief Medical Officer

Lara Meisner

Chief Legal Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BCAX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCAX\",,,,,undefined,":{"symbol":"BCAX","market":"US","secType":"STK","nameCN":"Bicara Therapeutics","latestPrice":15.51,"timestamp":1745438400000,"preClose":13.82,"halted":0,"volume":1175828,"hourTrading":{"tag":"盘后","latestPrice":15.51,"preClose":15.51,"latestTime":"17:52 EDT","volume":1932,"amount":29933.8,"timestamp":1745445152974},"delay":0,"floatShares":28372221,"shares":54523326,"eps":-4.045991,"marketStatus":"未開盤","change":1.69,"latestTime":"04-23 16:00:00 EDT","open":14.1,"high":16.22,"low":13.66,"amount":18074200.123848,"amplitude":0.185239,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.045991,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745481600000},"marketStatusCode":0,"adr":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":13.82,"preHourTrading":{"tag":"盘前","latestPrice":14.01,"preClose":13.82,"latestTime":"09:25 EDT","volume":38,"amount":531.089976,"timestamp":1745414717828},"postHourTrading":{"tag":"盘后","latestPrice":15.51,"preClose":15.51,"latestTime":"17:52 EDT","volume":1932,"amount":29933.8,"timestamp":1745445152974},"volumeRatio":2.551526,"impliedVol":0.5801,"impliedVolPercentile":0.4},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCAX\",,,,,undefined,":{"symbol":"BCAX","floatShares":28372221,"roa":"-13.84%","roe":"-19.14%","lyrEps":-4.045991,"volumeRatio":2.551526,"shares":54523326,"dividePrice":0,"high":16.22,"amplitude":0.185239,"preClose":13.82,"low":13.66,"week52Low":8.91,"pbRate":"1.72","week52High":28.09,"institutionHeld":0,"latestPrice":15.51,"eps":-4.045991,"divideRate":0,"volume":1175828,"delay":0,"ttmEps":-4.045991,"open":14.1,"prevYearClose":17.42,"prevWeekClose":12.16,"prevMonthClose":13.03,"prevQuarterClose":13.03,"fiveDayClose":11.45,"twentyDayClose":13.03,"sixtyDayClose":11.65},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":674698236,"yearFounded":2018,"employeeNum":55,"address":"116 Huntington Avenue,Suite 703,Boston,Massachusetts,United States","zipCode":"02116","officePhone":"617 468 4219"},"stockCompanyDetail":{"websiteUrl":"http://www.bicara.com","stockEarnings":[{"period":"1week","weight":0.207},{"period":"1month","weight":0.0438},{"period":"3month","weight":0.1594},{"period":"6month","weight":-0.3888},{"period":"1year","weight":-0.2322},{"period":"ytd","weight":-0.2067}],"compareEarnings":[{"period":"1week","weight":-0.0193},{"period":"1month","weight":-0.0651},{"period":"3month","weight":-0.1306},{"period":"6month","weight":-0.0898},{"period":"1year","weight":0.0551},{"period":"ytd","weight":-0.1004}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Bicara Therapeutics Inc.於2018年12月12日在特拉華州註冊成立。他們是一家臨床階段的生物製藥公司，致力於為實體瘤患者帶來變革性的雙功能療法。他們的主要項目阿法是一種雙功能抗體，它結合了兩個臨床驗證的靶點，即表皮生長因子受體（EGFR）導向的單克隆抗體和結合人類轉化生長因子β（TGF-b）的結構域。通過這種雙靶向機制，阿法有可能通過同時阻斷癌症細胞固有的EGFR存活和增殖，以及腫瘤微環境（TME）中的免疫抑制性TGF-b信號傳導，發揮強大的抗腫瘤活性。Ficerafusp alfa通過與腫瘤細胞上的EGFR結合，將TGF-b抑製劑直接引入TME，他們認為這將導致持久的反應和總生存率或OS的增加，同時減少通常與全身TGF-b抑制相關的不良反應。","exchange":"NASDAQ","name":"Bicara Therapeutics","nameEN":"Bicara Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BCAX\",market:\"US\",,,undefined,":{"directors":[{"name":"Claire Mazumdar","position":"Chief Executive Officer and Director"},{"name":"Michael Powell","position":"Chairperson of the Board"},{"name":"Ryan Cohlhepp, Pharm.D","position":"President, Chief Operating Officer and Director"},{"name":"Carolyn Ng","position":"Director"},{"name":"Christopher Bowden","position":"Director"},{"name":"Heath Lukatch","position":"Director"},{"name":"Jake Simson","position":"Director"},{"name":"Kate Haviland","position":"Director"},{"name":"Kiran Mazumdar Shaw","position":"Director"},{"name":"Nils Lonberg","position":"Director"},{"name":"Scott Robertson","position":"Director"},{"name":"Vijay Kuchroo, D.V.M","position":"Director"}],"executives":[{"name":"Claire Mazumdar","position":"Chief Executive Officer and Director"},{"name":"Ryan Cohlhepp, Pharm.D","position":"President, Chief Operating Officer and Director"},{"name":"Ivan Hyep","position":"Chief Financial Officer"},{"name":"David Raben","position":"Chief Medical Officer"},{"name":"Lara Meisner","position":"Chief Legal Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"BCAX","fiscalQuarterEnding":"2024/12","expectedEps":-0.31,"name":null,"time":"盤前","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.39},{"market":"US","date":"2024-11-12","symbol":"BCAX","fiscalQuarterEnding":"2024/09","expectedEps":-0.46,"name":null,"time":"盤前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.5714,"hold":0,"sell":0.1429,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1744948800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BCAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BCAX","date":"2025-04-22","current":-10.143688,"percent":0.926667,"low":-22.704836,"twenty":-19.02049,"median":-15.187116,"eighty":-11.307997,"high":-7.513546,"avg":-15.089006,"sd":3.993303,"marketCap":689720073},"quantilePoints":[{"date":"2024-09-13","current":-12.837909,"twenty":-12.837909,"median":-12.837909,"eighty":-12.837909,"marketCap":832435719},{"date":"2024-09-20","current":-20.633135,"twenty":-21.391361,"median":-20.283845,"eighty":-14.007791,"marketCap":1337893755},{"date":"2024-09-27","current":-21.555755,"twenty":-21.594337,"median":-21.446718,"eighty":-19.006626,"marketCap":1397718272},{"date":"2024-10-04","current":-19.962139,"twenty":-21.575885,"median":-21.337681,"eighty":-19.559541,"marketCap":1294385015},{"date":"2024-10-11","current":-15.936161,"twenty":-21.540658,"median":-20.570229,"eighty":-18.732598,"marketCap":1033332575},{"date":"2024-10-18","current":-17.143955,"twenty":-21.466848,"median":-20.283845,"eighty":-16.808457,"marketCap":1111648307},{"date":"2024-10-25","current":-18.964032,"twenty":-21.403103,"median":-19.23243,"eighty":-16.959431,"marketCap":1229665764},{"date":"2024-10-31","current":-19.878264,"twenty":-21.362844,"median":-19.23243,"eighty":-17.02653,"marketCap":1288946422},{"date":"2024-11-08","current":-19.79439,"twenty":-21.337681,"median":-19.82794,"eighty":-17.143955,"marketCap":1283507830},{"date":"2024-11-15","current":-20.345116,"twenty":-21.127995,"median":-19.949558,"eighty":-18.418848,"marketCap":1210086831},{"date":"2024-11-22","current":-16.257533,"twenty":-21.102833,"median":-19.82794,"eighty":-17.143955,"marketCap":966965549},{"date":"2024-11-29","current":-19.02049,"twenty":-20.975343,"median":-19.458892,"eighty":-17.009755,"marketCap":1131300719},{"date":"2024-12-06","current":-17.876882,"twenty":-20.695202,"median":-19.01323,"eighty":-17.12047,"marketCap":1063281195},{"date":"2024-12-13","current":-16.509127,"twenty":-20.532485,"median":-19.005969,"eighty":-17.12047,"marketCap":981929844},{"date":"2024-12-20","current":-15.187116,"twenty":-20.493904,"median":-18.892739,"eighty":-16.769874,"marketCap":903299275},{"date":"2024-12-27","current":-17.49263,"twenty":-20.458153,"median":-18.854995,"eighty":-16.764842,"marketCap":1040426635},{"date":"2025-01-03","current":-15.484454,"twenty":-20.399979,"median":-18.727694,"eighty":-16.641786,"marketCap":920984351},{"date":"2025-01-10","current":-13.952019,"twenty":-20.332862,"median":-18.565256,"eighty":-16.325863,"marketCap":829838189},{"date":"2025-01-17","current":-10.868852,"twenty":-20.271506,"median":-18.306879,"eighty":-15.951961,"marketCap":646457553},{"date":"2025-01-24","current":-10.951191,"twenty":-20.22215,"median":-18.224539,"eighty":-15.55307,"marketCap":651354959},{"date":"2025-01-31","current":-11.811185,"twenty":-20.138275,"median":-17.666458,"eighty":-14.949245,"marketCap":702505641},{"date":"2025-02-07","current":-11.52757,"twenty":-20.11652,"median":-17.561246,"eighty":-13.156068,"marketCap":685636799},{"date":"2025-02-14","current":-12.003311,"twenty":-19.978914,"median":-17.49263,"eighty":-12.003311,"marketCap":713932921},{"date":"2025-02-21","current":-12.643731,"twenty":-19.965494,"median":-17.085242,"eighty":-11.997822,"marketCap":752023854},{"date":"2025-02-28","current":-11.307997,"twenty":-19.942009,"median":-16.815614,"eighty":-11.891694,"marketCap":672577050},{"date":"2025-03-07","current":-14.409462,"twenty":-19.890007,"median":-16.73236,"eighty":-11.891694,"marketCap":857045999},{"date":"2025-03-14","current":-12.213735,"twenty":-19.838005,"median":-16.60519,"eighty":-11.893524,"marketCap":726448513},{"date":"2025-03-21","current":-11.975864,"twenty":-19.8011,"median":-16.394587,"eighty":-11.882546,"marketCap":712300452},{"date":"2025-03-28","current":-10.745093,"twenty":-19.525992,"median":-16.092853,"eighty":-11.882546,"marketCap":730612568},{"date":"2025-04-04","current":-9.486153,"twenty":-19.364339,"median":-15.936742,"eighty":-11.721526,"marketCap":645010946},{"date":"2025-04-11","current":-8.139007,"twenty":-19.311424,"median":-15.55307,"eighty":-11.500123,"marketCap":553411758},{"date":"2025-04-17","current":-9.430022,"twenty":-19.133936,"median":-15.269456,"eighty":-11.355571,"marketCap":641194313},{"date":"2025-04-22","current":-10.143688,"twenty":-19.02049,"median":-15.187116,"eighty":-11.307997,"marketCap":689720073}],"updateTime":1745464382041}}}